Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Clinical Investigation

• Publication date

  1987-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI112980PMID 3553241PMCID PMC424426
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modification of pulmonary responses to endotoxemia in awake sheep by steroidal and nonsteroidal anti-inflammatory agents.

  2015cited by this paper
• Inhibition of PAF-lnduced Systemic Responses in the Rat, Guinea Pig, Dog and Primate by the Receptor Antagonist SRI 63-441

  1986cited by this paper
• Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.

  1986cited by this paper
• Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes

  1986cited by this paper
• Platelet-activating factor causes pulmonary vasodilation in the rat.

  1986cited by this paper
• PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung.

  1986cited by this paper
• Shock and tissue injury induced by recombinant human cachectin.

  1986cited by this paper
• Effect of PAF-acether antagonists, RP 48740 and BN 52021, on platelet activation and bronchoconstruction induced by PAF-acether and structural analogues in guinea-pig

  1985cited by this paper
• Species variations in the pulmonary responses to arachidonic acid metabolites.

  1985cited by this paper
• Production of peptide leukotrienes in endotoxin shock

  1985cited by this paper
• Effect of endotoxemia on hypoxic pulmonary vasoconstriction in unanesthetized sheep.

  1985cited by this paper
• Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.

  1985cited by this paper
• Synthesis of PAF-acether and blood volume changes in gram-negative sepsis.

  1985cited by this paper
• Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

  1985cited by this paper
• Association of platelet-activating factor with primary acquired cold urticaria.

  1985cited by this paper
• Protective effect of a selective leukotriene antagonist in endotoxemia in the rat.

  1985cited by this paper
• Is platelet activating factor (PAF) a mediator of endotoxin shock?

  1985cited by this paper
• Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys.

  1984cited by this paper
• Effect of platelet activating factor on endothelial permeability to plasma macromolecules.

  1984cited by this paper
• 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.

  1984cited by this paper
• Neutrophil alveolitis following endotoxemia. Enhancement by previous exposure to hyperoxia.

  1984cited by this paper
• Quantitation of leukocytes in bronchoalveolar lavage samples from rats after intravascular injection of endotoxin.

  1984cited by this paper
• Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists.

  1984cited by this paper
• Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia.

  1984cited by this paper
• Pathophysiological mechanisms of sudden death induced by platelet activating factor

  1984cited by this paper
• The release of platelet-activating factor from human endothelial cells in culture.

  1983cited by this paper
• Multiple comparisons by rerandomization tests

  1983cited by this paper
• CV-3988 - a specific antagonist of platelet activating factor (PAF).

  1983cited by this paper
• The biologic activity of mast cell granules. VI. The effect of vinblastine-induced neutropenia on rat cutaneous late phase reactions.

  1983cited by this paper
• Septicemia and lung injury.

  1983cited by this paper
• Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.

  1983cited by this paper
• Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure:function relationships.

  1983cited by this paper
• Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.

  1983cited by this paper
• Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.

  1983cited by this paper
• Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report.

  1983cited by this paper
• Release of platelet activating factor in rabbits with antibody-mediated injury of the lung: the role of leukocytes and of pulmonary endothelial cells.

  1983cited by this paper
• Hypotensive activity of PAF-acether in rats

  1982cited by this paper
• PULMONARY MICROCIRCULATORY HEMODYNAMICS *

  1982cited by this paper
• Nonimmunological production of leukotrienes induced by platelet-activating factor.

  1982cited by this paper
• PULMONARY MICROVASCULAR ALTERATIONS AND INJURY INDUCED BY COMPLEMENT FRAGMENTS: SYNERGISTIC EFFECT OF COMPLEMENT ACTIVATION, NEUTROPHIL SEQUESTRATION, AND PROSTAGLANDINS *

  1982cited by this paper
• Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs.

  1981cited by this paper
• Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

  1981cited by this paper
• Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep.

  1981cited by this paper
• Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia.

  1981cited by this paper
• Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.

  1980cited by this paper
• Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

  1979cited by this paper
• Estimation of the filtration coefficient of pulmonary exchange vessels.

  1978cited by this paper
• Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response

  1976cited by this paper
• On-line cardiac output by digital computer.

  1976cited by this paper
• Endotoxin and prevention of hypoxic pulmonary vasoconstriction.

  1976cited by this paper
• Inhibition of Hypoxic Pulmonary Vasoconstriction by Calcium Antagonists in Isolated Rat Lungs

  1976cited by this paper
• Cardiac output by dye dilution in the conscious rat.

  1974cited by this paper
• Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils

  1974cited by this paper
• Acute immunologic pulmonary alveolitis.

  1974cited by this paper
• Principles and procedures of statistics.

  1961cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• A METHOD FOR JUDGING ALL CONTRASTS IN THE ANALYSIS OF VARIANCE

  1953cited by this paper

• Piper kadsura (Choisy) Ohwi: A comprehensive review of botany, traditional uses, phytochemistry, pharmacology, and quality control.

  2025cites this paper
• Platelet-mediated activation of perivascular mast cells triggers progression of sepsis to septic shock in mice

  2025cites this paper
• Augmented anti-tumour effect of lipopolysaccharide with G-CSF without enhancing body weight reduction in mice bearing MH134 hepatoma.

  2022cites this paper
• Analysis of flow resistance in the pulmonary arterial circulation: Implications for hypoxic pulmonary vasoconstriction.

  2021cites this paper
• Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems

  2020cites this paper
• Plasmin cascade mediates thrombolytic events in SARS-CoV-2 infection via complement and platelet-activating systems

  2020cites this paper
• Etiology and Prevention of Multisystem Organ Failure

  2018cites this paper
• Evaluation of platelet activating factor in neonatal calves with sepsis

  2018cites this paper
• Respiratory gas exchange as a new aid to monitor acidosis in endotoxemic rats: relationship to metabolic fuel substrates and thermometabolic responses

  2017cites this paper
• The accumulation of lipids and proteins during red blood cell storage: the roles of leucoreduction and experimental filtration.

  2017cites this paper
• 130 – Neonatal Pulmonary Host Defense

  2017cites this paper
• Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance

  2016cites this paper
• Polymicrobial infections involving clinically relevant Gram‐negative bacteria and fungi

  2016cites this paper
• Biosynthesis of oxidized lipid mediators via lipoprotein-associated phospholipase A2 hydrolysis of extracellular cardiolipin induces endothelial toxicity.

  2016cites this paper
• increasing pulmonary arterial pressure in the rat PAF increases vascular permeability without

  2015cites this paper
• vasomotor tone in the perinatal lamb Platelet-activating factor modulates pulmonary

  2015cites this paper
• Platelet-activating factor is a potent pyrogen and cryogen, but it does not mediate lipopolysaccharide fever or hypothermia

  2015cites this paper
• Platelet Vascular Endothelial Growth Factor is a Potential Mediator of Transfusion-Related Acute Lung Injury

  2014cites this paper
• Flaxseed and endotoxic shock.

  2014cites this paper
• Platelet-activating Factor Contributes to Bacillus anthracis Lethal Toxin-associated Damage*

  2014cites this paper
• Differential Regulation of Lung Endothelial Permeability in Vitro and in Situ

  2014cites this paper
• HMGB1 Accelerates Alveolar Epithelial Repair via an IL-1β- and αvβ6 Integrin-dependent Activation of TGF-β1

  2013cites this paper
• HMGB 1 Accelerates Alveolar Epithelial Repair via an IL-1 band a v b 6 Integrin-dependent Activation of TGF-b 1

  2013cites this paper
• Important Role of Platelets in Modulating Endotoxin-Induced Lung Inflammation in CFTR-Deficient Mice

  2013cites this paper
• CD4+CD25+ Regulatory T Cells Attenuate Lipopolysaccharide-Induced Systemic Inflammatory Responses and Promotes Survival in Murine Escherichia coli Infection

  2013cites this paper
• Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration

  2013cites this paper
• Effect of dietary L-arginine supplementation on edema disease

  2012cites this paper
• Effect of dietary L-glutamine supplementation on edema disease induced by Escherichia coli

  2012cites this paper
• Chapter 31 – Etiology and prevention of multisystem organ failure

  2012cites this paper
• Free Radicals in Diagnostic Medicine

  2012cites this paper
• Bacteremia Does Not Affect Cellular Uptake of Ultrafine Particles in the Lungs of Rats

  2011cites this paper
• Cysteinyl Leukotrienes Impair Hypoxic Pulmonary Vasoconstriction in Endotoxemic Mice

  2011cites this paper
• Enhancement of endothelial permeability by coculture with peripheral blood mononuclear cells in the presence of HLA Class II antibody that was associated with transfusion‐related acute lung injury

  2011cites this paper
• 輸血関連急性肺障害に関与した抗HLA Class II抗体陽性血漿と末梢血単核細胞及び血管内皮細胞の共培養による内皮細胞の透過性亢進

  2011cites this paper
• Optimization of cell-based assays to quantify the anti-inflammatory/allergic potential of test substances in 96-well format

  2011cites this paper
• New Modalities in Treating Pneumococcal Pneumonia

  2011cites this paper
• Effects of ketamine on hypoxic pulmonary vasoconstriction in the isolated perfused lungs of endotoxaemic mice

  2010cites this paper
• Effects of lidocaine infusion during experimental endotoxemia in horses.

  2010cites this paper
• Decrease of Plasma Platelet-Activating Factor Acetylhydrolase Activity in Lipopolysaccharide Induced Mongolian Gerbil Sepsis Model

  2010cites this paper
• Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.

  2010cites this paper
• Effects o f Lidocaine I nfusion d u ring E xperimental E ndotoxemia in H orses

  2010cites this paper
• Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.

  2009cites this paper
• Capítulo 23 – Etiología y prevención del fracaso multiorgánico

  2009cites this paper
• Inibição do edema pulmonar em camundongos por bloqueadores das fosfodiesterases

  2008cites this paper
• Hypoxia increases plasma glutathione disulfide in rats

  2007cites this paper
• Lung production of platelet-activating factor acetylhydrolase in oleic acid-induced acute lung injury.

  2007cites this paper
• Regulation of surfactant secretion in alveolar type II cells.

  2007cites this paper
• UvA-DARE ( Digital Academic Repository ) Pneumomia : an investigation of host defence mechanisms

  2007cites this paper
• Role of platelet-activating factor in pneumolysin-induced acute lung injury

  2007cites this paper
• Chapter 32 – Etiology and prevention of multisystem organ failure

  2007cites this paper
• 4-Aminopyridine Restores Impaired Hypoxic Pulmonary Vasoconstriction in Endotoxemic Mice

  2007cites this paper
• Lexipafant (BB-882): A Potent New Platelet-Activating Factor Receptor Antagonist

  2007cites this paper
• Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants.

  2006cites this paper
• Myocardial Depression in Sepsis and Septic Shock

  2006cites this paper
• Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.

  2006cites this paper
• Effect of a Antagonist Septicemia Platelet Activating Factor and Antithrombin III on and Endotoxemia in Rats

  2006cites this paper
• EXOGENOUS PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE REDUCES MORTALITY IN MICE WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AND SEPSIS

  2006cites this paper
• Lipid Mediators of Tumor Necrosis Facfor-a-lnduced Uveitis

  2005cites this paper
• The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema

  2005cites this paper
• Chapter 14 Chronic lung vascular hyperpermeability

  2005cites this paper
• Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung.

  2005cites this paper
• A dual inhibitor of TNF-alpha and IL-1 mitigates liver and kidney dysfunction and improves survival in rat endotoxemia.

  2005cites this paper
• Molecular mechanisms underlying inflammatory lung diseases in the elderly: Development of a novel therapeutic strategy for acute lung injury and pulmonary fibrosis

  2005cites this paper
• Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase.

  2005cites this paper
• 5-Lipoxygenase deficiency prevents respiratory failure during ventilator-induced lung injury.

  2005cites this paper
• Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications

  2004cites this paper
• Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation

  2004cites this paper
• Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature

  2004cites this paper
• Chapter 164 – Neonatal Pulmonary Host Defense Mechanisms

  2004cites this paper
• PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide

  2004cites this paper
• Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications.

  2004cites this paper
• The platelet activating factor as a pivotal mediator of shock after liver ischemia

  2004cites this paper
• Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.

  2004cites this paper
• Interaction between inflammation, coagulation and fibrinolysis during infection

  2004cites this paper
• Platelet-Activating Factor Synthesis by Neutrophils, Monocytes, and Endothelial Cells is Modulated by Nitric Oxide Production

  2003cites this paper
• Nutritionally Regulated Hormonal Factors in Prolonged Postnatal Growth Retardation and Its Associated Adverse Neurodevelopmental Outcome in Extreme Prematurity

  2003cites this paper
• PLATELET‐ACTIVATING FACTOR ACETYLHYDROLASE INHIBITS ALVEOLAR MACROPHAGE ACTIVATION IN VIVO

  2003cites this paper
• Gene Expression of Surfactant Protein A mRNA of the Lung in Endotoxin and Thiourea Treated Rats

  2003cites this paper
• Gene expression of surfactant protein B and C in endotoxin and thiourea treated rats

  2003cites this paper
• Platelet‐Activating Factor: A Previously Unrecognized Mediator of Fever

  2003cites this paper
• Plasma and lipids from stored platelets cause acute lung injury in an animal model

  2003cites this paper
• Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome

  2003cites this paper
• Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.

  2003cites this paper
• Targets for pharmacological intervention of endothelial hyperpermeability and barrier function.

  2002cites this paper
• Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels.

  2002cites this paper
• Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model

  2002cites this paper
• Vascular pharmacology of acute lung injury and acute respiratory distress syndrome.

  2002cites this paper
• The Macrophage Response to Endotoxin Requires Platelet Activating Factor

  2002cites this paper
• Receptor-dependent Metabolism of Platelet-activating Factor in Murine Macrophages*

  2002cites this paper
• Lipopolysaccharide-Induced Leukocyte Lipid Body Formation In Vivo: Innate Immunity Elicited Intracellular Loci Involved in Eicosanoid Metabolism1

  2002cites this paper
• Reactive Oxygen Species Scavengers Attenuate Endotoxin-induced Impairment of Hypoxic Pulmonary Vasoconstriction in Mice

  2002cites this paper
• The Immunology of Trauma and Its Sequelae

  2002cites this paper
• Targets for pharmacological intervention of endothelial hyperpermeability and barrier function.

  2002cites this paper
• Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes.

  2002cites this paper
• Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats.

  2002cites this paper
• The Role of Platelet-Activating Factor in Sepsis: A Bench-to-Bedside Review

  2002cites this paper
• Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis.

  2002cites this paper
• Intracellular Loci Involved in Body Formation In Vivo : Innate Immunity Lipopolysaccharide-Induced Leukocyte Lipid and

  2002cites this paper
• Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces.

  2002cites this paper
• Clinical developments for treating ARDS

  2002cites this paper